- Trials with a EudraCT protocol (10,192)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10,192 result(s) found.
Displaying page 1 of 510.
EudraCT Number: 2017-004506-18 | Sponsor Protocol Number: LYMRIT-37-07 | Start Date*: 2018-06-13 | |||||||||||
Sponsor Name:Nordic Nanovector ASA | |||||||||||||
Full Title: A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1) | |||||||||||||
Medical condition: Follicular lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003461-17 | Sponsor Protocol Number: 71272 | Start Date*: 2020-01-07 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF) | ||
Medical condition: Heart failure with preserved ejection fraction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002078-30 | Sponsor Protocol Number: NL70122.078.20 | Start Date*: 2020-06-19 |
Sponsor Name:Erasmus MC | ||
Full Title: Autoimmune epilepsy Modulated by IVIg – effects on Cortical Excitability, the AMICE study | ||
Medical condition: Auto-immune epilepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010093-38 | Sponsor Protocol Number: HyRec | Start Date*: 2012-08-15 | ||||||||||||||||||||||||||
Sponsor Name:Dekan of the Medical Faculty of the University Erlangen-Nuremberg; Prof. Dr. Dr. h. c. Jürgen Schüttler | ||||||||||||||||||||||||||||
Full Title: Multi-institutional Phase I/II Study: Neoadjuvant chemoradiation with 5-FU (or capecitabine) and oxaliplatin combined with deep regional hyperthermia in locally advanced or recurrent rectal cancer | ||||||||||||||||||||||||||||
Medical condition: Locally advanced primary or locally recurrent rectal cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000449-11 | Sponsor Protocol Number: EP250567 | Start Date*: 2012-03-01 | |||||||||||
Sponsor Name:Eero Pesonen | |||||||||||||
Full Title: Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting | |||||||||||||
Medical condition: Patients undergoing elective coronary artery bypass grafting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000550-60 | Sponsor Protocol Number: V7/22032018 | Start Date*: 2014-01-17 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3 | |||||||||||||
Full Title: Pulsed oral sirolimus in autosomal dominant polycystic kidney disease | |||||||||||||
Medical condition: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the development and uncontrolled proliferation of innumerable epithelial-lined cysts that stem from renal... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002226-23 | Sponsor Protocol Number: 2013-002226-23 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Bergen, Department of Global Public Health and Primary Care | ||
Full Title: Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy | ||
Medical condition: Depression Pain Dementia | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005279-18 | Sponsor Protocol Number: RG_11-164 | Start Date*: 2012-02-08 | ||||||||||||||||
Sponsor Name:University of Birmingham | ||||||||||||||||||
Full Title: A RandoMised study of best Available therapy versus JAK Inhibition in patients with high risk Polycythaemia Vera or Essential Thrombocythaemia who are resistant or intolerant to HydroxyCarbamide. | ||||||||||||||||||
Medical condition: Polycythaemia vera Essential Thrombocythaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015316-17 | Sponsor Protocol Number: 01AneInt2009 | Start Date*: 2017-11-17 | |||||||||||
Sponsor Name:Oslo Universitetssykehus - Rikshospitalet | |||||||||||||
Full Title: Perioperativ administrasjon av pregabalin ved laparoskopisk living donor nefrektomi (L-LDN) - et adjuvans til peroral analgetisk behandling - en randomisert kontrollert studie | |||||||||||||
Medical condition: Hensikten med studien er å undersøke om perioperativ administrasjon av pregabalin vil redusere postoperativ smerte og forbruket av intravenøse opioider postoperativt sammenliknet med dagens standar... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002255-42 | Sponsor Protocol Number: MK-3222-010 | Start Date*: 2013-01-10 | |||||||||||
Sponsor Name:Sun Pharma Global FZE | |||||||||||||
Full Title: A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222), Followed by an Optiona... | |||||||||||||
Medical condition: Moderate-to-Severe Chronic Plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000919-22 | Sponsor Protocol Number: OMB114578 | Start Date*: 2011-09-14 | |||||||||||
Sponsor Name:University of Liverpool [...] | |||||||||||||
Full Title: RIAltO: A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL | |||||||||||||
Medical condition: Chronic Lymphocytic Leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004787-62 | Sponsor Protocol Number: DUS | Start Date*: 2014-11-26 | |||||||||||
Sponsor Name:SOD Anestesia e Terapia Intensiva, DAI Oncologia, AOU Careggi, Firenze | |||||||||||||
Full Title: Evaluation of muscle function recovery after deep neuromuscular blockade by acceleromyography of the adductor pollicis or diaphragmatic echography: comparison between sugammadex and neostigmine | |||||||||||||
Medical condition: Muscle function recovery post neuromuscoular blockade | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005095-28 | Sponsor Protocol Number: IRST186.02 | Start Date*: 2015-04-16 | |||||||||||
Sponsor Name:ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS | |||||||||||||
Full Title: Olaparib as salvage treatment for cisplatin-resistant germ cell tumor. | |||||||||||||
Medical condition: cisplatin-resistant germ cell tumor | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004978-34 | Sponsor Protocol Number: RBHP2017BACHOUMAS | Start Date*: 2018-12-04 |
Sponsor Name:CHU de Clermont-ferrand | ||
Full Title: Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients. An open-label parallel randomized controlled pilot study | ||
Medical condition: - Hypermetabolism in ICU, loss of muscle mass and functional disability after ICU - ICU acquired hypogonadism - Treatment with testosterone gel in ICU | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000724-10 | Sponsor Protocol Number: 60978 | Start Date*: 2018-07-04 |
Sponsor Name:Academic Medical Center | ||
Full Title: Targeting esophageal cancer with HDL nanoparticles: an imaging study | ||
Medical condition: Primary esophageal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001563-74 | Sponsor Protocol Number: PHRCN2018/LEVOHEARTSHOCK-LEVY/YB | Start Date*: 2020-07-24 | |||||||||||
Sponsor Name:CHRU de Nancy | |||||||||||||
Full Title: Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. LevoHeartShock St... | |||||||||||||
Medical condition: Cardiogenic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004419-35 | Sponsor Protocol Number: GN13RH410 | Start Date*: 2015-03-18 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: Inhibition of Co-Stimulation in Rheumatoid Arthritis | |||||||||||||
Medical condition: Rheumatoid Arthritis: patients who are dual ACPA and HLA-DR4 positive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002597-12 | Sponsor Protocol Number: 013-IRCC-10IIS-16 | Start Date*: 2017-03-09 | |||||||||||
Sponsor Name:FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCCS | |||||||||||||
Full Title: A PHASE II TRIAL OF RECHALLENGE WITH PANITUMUMAB DRIVEN BY RAS CLONAL-MEDIATED DYNAMIC OF RESISTANCE. THE CHRONOS TRIAL. | |||||||||||||
Medical condition: METASTATIC COLORECTAL CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004299-37 | Sponsor Protocol Number: CA209-8U4 | Start Date*: 2019-01-24 | ||||||||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | ||||||||||||||||||
Full Title: NIVOLUMAB plus IPILIMUMAB and TEMOZOLOMIDE in combination in microsatellite stable (MSS), MGMT silenced metastatic colorectal cancer (mCRC): the MAYA study. | ||||||||||||||||||
Medical condition: Microsatellite stable (MSS), MGMT-silenced metastatic colorectal carcinoma (mCRC). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000580-90 | Sponsor Protocol Number: ASSTBS-ONCO-ACACIA-18 | Start Date*: 2018-06-20 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Multicenter randomized open-label phase III trial of Adjuvant Chemotherapy vs. observation or mitotane after primary surgical resection of localized | |||||||||||||
Medical condition: localized Adrenocortical CarcInomA with high risk of recurrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
